Facebook
X
LinkedIn
Forward
Precision at Scale: Translating the Evolving Biomarker Landscape in NSCLC Into Strategies for Timeline and Targeted Care
Wednesday, November 11, 2026 at 12:00 PM–1:00 PM EST Pricing: Free for Members and $99 for Non-Members
Program Description
While mortality rates from non–small cell lung cancer (NSCLC) have decreased significantly in recent years, NSCLC remains the leading cause of cancer-related death. The advent and rapid evolution of precision oncology have fundamentally altered the treatment landscape, as an expanding array of actionable biomarkers now inform the use of highly effective targeted therapies and immunotherapies throughout the disease continuum, improving survival rates.
This session explores the evolving NSCLC landscape, emerging treatment options, and the role of managed care in supporting timely, equitable access to biomarker-driven care. Participants will review current evidence, guideline updates, and practical strategies for integrating precision medicine into coverage decisions, formulary management, and patient access programs.
This activity is supported by an independent medical education grant from Boehringer Ingelheim Pharmaceuticals, Inc and Regeneron Pharmaceuticals.
Target Audience
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
Learning Objectives
At the completion of this program, participants should be able to:
- Review the impact of genomic profiling and molecular subtyping in NSCLC classification, treatment selection, and individualized therapeutic approaches to optimize patient outcomes.
- Identify key emerging precision therapies in NSCLC, focusing on enhanced treatment efficacy, minimizing adverse effects, and improving the quality of life for NSCLC patients.
- Identify payer strategies to address gaps and delays in access to precision medicine for NSCLC patients, including policy and benefit design considerations.
Course summary
- 1.00 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.00 Certificate of Completion
Speakers:
Bret Jackson
President and CEO
Economic Alliance for Michigan
Daryl Pritchard, PhD
Senior Advisory Consultant, Science Policy
Personalized Medicine Coalition
ACPE UAN: 0233-0000-26-059-L04-P
Activity Type: Knowledge-Based
Contact Hours: 1.00
Release Date: November 11, 2026
Expiration Date: December 7, 2026
Activity Fee: Free for Members and $99 for Non-Members
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher).
- Complete a specific activity evaluation.
Available Credit
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.00 Certificate of Completion
Price
By registering for this event, you agree not to use any form of artificial intelligence (AI) technology to record, transcribe, or reproduce educational sessions, presentations, or discussions in any format.
Click here for more information on AMCP membership or email memberservices@amcp.org.
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.